Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature

BMJ Case Reports
Christopher David Swan, Thomas Gottlieb

Abstract

We report a case of Cryptococcus neoformans pulmonary infection complicated by empyema in a 79-year-old man with diffuse large B-cell lymphoma treated with R-CHOP and ibrutinib. A literature review identified 25 cases of cryptococcal pleural disease published since 1980. Most cases were caused by the C. neoformans species in immunocompromised hosts with an exudative pleural effusion and lymphocyte-predominant infiltrate. The cryptococcal antigen test was often positive when pleural fluid and serum were tested. The outcome was favourable in most cases with antifungal therapy and either thoracocentesis or surgical resection. We also identified 40 cases of opportunistic infections, most commonly aspergillosis, cryptococcosis and Pneumocystis jirovecii pneumonia, in patients treated with ibrutinib. In vitro studies indicate Bruton tyrosine kinase inhibition impairs phagocyte function and offer a mechanism for the apparent association between ibrutinib and invasive fungal infections.

References

Feb 11, 1992·Chest·M F TenholderJ H Crosby
May 1, 1991·The American Journal of the Medical Sciences·E E GrumM L Margolis
Apr 1, 1990·Journal of Thoracic Imaging·D J ConcesR D Tarver
Aug 1, 1980·The Journal of Infectious Diseases·C F Winkler, L T Yam
May 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V E MulanovichN Markowitz
Oct 26, 1999·Postgraduate Medical Journal·C M WongC K Liam
Jan 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Venkataraman RamanathanJ Harold Helderman
Jan 21, 2004·Respiration; International Review of Thoracic Diseases·A A G de KlerkC T Bolliger
Oct 19, 2005·The Journal of Infection·Wei-Chou ChangCheng-Yu Chen
Apr 18, 2006·Seminars in Oncology·Punit D Wadhwa, Vicki A Morrison
Aug 10, 2006·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Esaki Muthu ShankarUsha Anand Rao
May 2, 2009·Respiration; International Review of Thoracic Diseases·Yusuke YoshinoKazuhiko Koike
Sep 19, 2009·Clinical Nephrology·K KinjoT Ohama
Mar 20, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lindsey B RosenSarah K Browne
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Jun 3, 2014·The New England Journal of Medicine·John C ByrdUNKNOWN RESONATE Investigators
Jul 6, 2014·Cold Spring Harbor Perspectives in Medicine·Kyung J Kwon-ChungYong-Sun Bahn
Apr 24, 2015·Annals of Hematology·Song-Yau WangHaifa Kathrin Al-Ali
Apr 21, 2016·The New England Journal of Medicine·Jan A BurgerThomas J Kipps
Jul 28, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Mathias LutzWolfgang E Berdel
Oct 6, 2016·Case Reports in Infectious Diseases·Koh OkamotoPatricia L Demarais
Dec 14, 2016·The Lancet Oncology·Meletios A DimopoulosUNKNOWN iNNOVATE Study Group and the European Consortium for Waldenström's Macroglobulinemia
Feb 6, 2017·Hematological Oncology·Natalia KreinizTamar Tadmor
Feb 12, 2017·Annals of Hematology·Thomas S Y ChanYok-Lam Kwong
Feb 24, 2017·SAGE Open Medical Case Reports·Ali RaufiYehuda Lebowicz
Mar 3, 2017·Journal of Natural Science, Biology, and Medicine·Amer HawatmehFayez Shamoon
Apr 6, 2017·Respiratory Medicine Case Reports·Benjamin ArthursSuil Kim
May 2, 2017·Annals of Internal Medicine·David P Serota
May 10, 2017·Open Forum Infectious Diseases·Julia A MessinaJohn R Perfect
May 30, 2017·Cancer Cell·Michail S LionakisWyndham H Wilson

❮ Previous
Next ❯

Citations

Jul 12, 2019·Medical Mycology·Christina C Chang, Stuart M Levitz
Feb 1, 2019·BMJ Case Reports·Tajwar NasirJeremy S Brown
Mar 12, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrUNKNOWN Cryptococcus Infection Network Cohort Study Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.